Laureate, ZZ Biotech Enter Mfg. Pact

Laureate Pharma has entered into a development and manufacturing agreement with ZZ Biotech, LLC, under which Laureate will produce Activated Protein C variant under cGMP conditions. Terms of the agreement were not disclosed.

“We are pleased that ZZ Biotech has chosen Laureate as their manufacturing partner,” said Robert J. Broeze, Ph.D., president and chief executive officer of Laureate. “We will work closely with their team and help them drive their product from development into the clinic.”

“Laureate Pharma has a proven track record in biopharmaceutical manufacturing, including capabilities in both clinical and commercial-scale grade materials,” said Berislav V. Zlokovic, M.D., Ph.D. founder and chief scientific officer of ZZ Biotech. “This agreement enables us to operationally leverage Laureate’s expertise and infrastructure while we seek to establish new treatment for stroke and neurodegenerative disorders.”